S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Pinnacle Fertility Enters South Carolina Market with Adore Acquisition

Mount Pleasant’s Adore Fertility is joining the national Pinnacle Fertility network, marking the organization’s first expansion into South Carolina. Founded by Dr. Jeris Cox in 2021, the clinic will be rebranded as Pinnacle Fertility South Carolina, integrating local physician-led care with the platform's broader reproductive technology and pharmacy resources.

Pinnacle Fertility Enters South Carolina Market with Adore Acquisition
Photo: Bio & News

The partnership allows Adore Fertility to maintain its clinical autonomy while gaining access to Pinnacle’s specialized infrastructure, including the Pinnacle Egg Bank, Pinnacle Surrogacy, and NewEra Pharmacy. Dr. Jeris Cox, a board-certified specialist in reproductive endocrinology and infertility, will continue to lead the practice, focusing on fertility preservation and advanced surgical care.

Beth Zoneraich, CEO of Pinnacle Fertility, stated that the acquisition aligns with the company’s strategy of supporting physician-led practices through operational scale. For patients in the Mount Pleasant region, the transition promises expanded access to integrated family-building services without sacrificing the personalized care model established by Dr. Cox. Pinnacle Fertility, headquartered in Scottsdale, Arizona, continues to aggressively grow its national footprint by absorbing clinics that prioritize patient-centered reproductive outcomes.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!